brain-derived microtubule-associated protein tau in serum/plasma
Jump to navigation
Jump to search
Indications
- may be useful for evaluation of tauopathy
- may be useful for detecting Alzheimer's-related neurodegeneration & differentiating Alzheimer's disease from other neurodegenerative diseases[1]
Clinical significance
- correlates with microtubule-associated protein tau in CSF
Procedure
- brain-derived microtubule-associated protein tau differs from peripherally-derived tau that contains an exon 4a insert between exons 4 & 5*
- an antibody that binds to an expressed glutathione-S-transferase-protein-linked protein construct for the MAPT gene exons 4-5 & of tau recombinant full length tau-441 was developed
- the resulting TauJ.5H3 monoclonal antibody demonstrates specific reactivity to the junction between MAPT exons 4 & 5, excluding tau of peripheral origin with an exon 4a insert
- levels of brain-derived microtubule-associated protein tau in serum/plasma using the TauJ.5H3 monoclonal correlate microtubule-associated protein tau in CSF[1]
More general terms
Additional terms
References
- ↑ 1.0 1.1 1.2 George J Novel Blood Test Detects Alzheimer's Neurodegeneration. Brain-derived tau distinguished Alzheimer's from other dementias. MedPage Today December 30, 2022 https://www.medpagetoday.com/neurology/alzheimersdisease/102459
Gonzales-Ortiz F, Turton M, Kac PR et al Brain-derived tau: a novel blood-based biomarker for Alzheimer's disease- type neurodegeneration. Brain. 2022. Dec 27. PMID: https://www.ncbi.nlm.nih.gov/pubmed/36572122 https://academic.oup.com/brain/advance-article/doi/10.1093/brain/awac407/6960988